Gelonghui, January 30 | Lanfan Healthcare (002382.SZ) announced its 2023 annual results forecast. Net profit loss attributable to shareholders of listed companies during the reporting period was 51 million yuan to 61 million yuan, down 36.98%-63.84% from the same period last year; net profit loss after deducting non-recurring profit and loss ratio of 58,000 yuan to 68,000 yuan; basic earnings loss per share of 0.51 yuan/share - 0.61 yuan/share.
During the reporting period, the company's net profit after deducting non-recurring profit and loss did not change much compared to the same period last year, which is expected to reflect a loss decrease of 11.74% to an increase of 3.47%. However, due to differences in non-recurring profit and loss items such as investment income of Suzhou Tongxin Medical Technology Co., Ltd. (hereinafter referred to as “Suzhou Tongxin”), net profit attributable to shareholders of listed companies fluctuated greatly.